600796.SH
钱江生化
SSE · Basic Materials · Agricultural Inputs · CN
CNY 5.09
+0.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.7B | 1.8B | 2.0B | 2.0B |
| Cost of Revenue | 1.2B | 1.3B | 1.4B | 1.6B | 1.6B |
| Gross Profit | 423.8M | 418.6M | 406.6M | 478.8M | 441.2M |
| Operating Expenses | |||||
| R&D Expense | 25.5M | 27.8M | 29.8M | 28.4M | 31.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 117.0M | 123.2M | 143.7M | 149.3M | 134.9M |
| Selling & Marketing Expense | 13.4M | 13.7M | 16.1M | 17.2M | 15.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 237.9M | 251.8M | 279.8M | 297.9M | 282.9M |
| Cost and Expenses | 1.4B | 1.5B | 1.6B | 1.9B | 1.9B |
| Operating Income (EBIT) | 208.4M | 198.5M | 164.4M | 230.8M | 244.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 211.3M | 201.4M | 174.3M | 228.8M | 240.3M |
| Income Tax Expense | 42.2M | 45.8M | 49.0M | 45.9M | 50.2M |
| Bottom Line | |||||
| Net Income | 172.4M | 166.4M | 160.0M | 210.7M | 206.0M |
| Earnings from Cont. Ops | 182.3M | 168.8M | 184.7M | 182.9M | 190.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 172.4M | 166.4M | 160.0M | 210.7M | 206.0M |
| Per Share | |||||
| Basic EPS | CN¥0.19 | CN¥0.19 | CN¥0.18 | CN¥0.24 | CN¥0.24 |
| Diluted EPS | CN¥0.19 | CN¥0.19 | CN¥0.18 | CN¥0.24 | CN¥0.24 |
| Revenue Per Share | CN¥1.79 | CN¥1.93 | CN¥1.99 | CN¥2.32 | CN¥2.34 |
| Shares | |||||
| Basic Shares Outstanding | 914.3M | 875.6M | 888.9M | 877.9M | 858.5M |
| Diluted Shares Outstanding | 914.3M | 875.6M | 888.9M | 877.9M | 858.5M |
| Profitability Metrics | |||||
| EBITDA | — | 397.3M | 403.7M | 460.3M | 482.7M |
| D&A | — | 198.8M | 239.4M | 229.5M | 238.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026